All News

Science|Business speaks to Professor Matthias Kleiner, President of the Deutsche Forschungsgemeinschaft, about the impact of the Excellence Initiative on German higher education.

A new campaign seeks to persuade regulators to set new rules for approving personalised treatments that are currently in clinical development.

The new Karlsruhe Institute of Technology is the most dramatic example of Germany's attempt to break down walls within academia.

After resigning as Vice President of Research at ETH Zurich over a case involving falsification of scientific data, Peter Chen says why his resignation “was inevitable”.

The European Commission’s probe into suspected anti-trust activity in the pharmaceutical sector is rumbling on, with further dawn raids earlier this week.